CytoDyn Cash Flow Statement (2010-2026) | CYDY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	May2021	Aug2021	Nov2021	Feb2022	May2022	Aug2022	Nov2022	Feb2023	May2023	Aug2023	Nov2023	Feb2024	May2024	Aug2024	Nov2024	Feb2025	May2025	Aug2025	Nov2025	Feb2026
Operating Activities
Net Income (Quarter)	-70.07M	-45.34M	-40.08M	-41.28M	-84.12M	-20.99M	-26.50M	-13.70M	-18.61M	-11.57M	-9.56M	-11.92M	-16.79M	19.23M	-4.77M	-4.76M	-5.96M	-5.54M	-22.61M	-4.69M
Share-based Compensation (Quarter)	1.38M	2.60M	2.10M	-0.40M	2.02M	0.34M	0.31M	0.18M	0.72M	0.15M	0.10M	0.90M	0.47M	0.14M	0.54M	0.04M	0.60M	0.18M	1.40M	0.44M
Deferred Taxes (Quarter)
Asset Writedowns and Impairment (Quarter)	-9.77M	1.76M	1.59M	5.56M	64.57M	2.70M	16.30M
Cash from Operations (Quarter)	-32.81M	-31.74M	-28.89M	-11.05M	-6.04M	-11.07M	-4.41M	-6.22M	-3.41M	-4.50M	-2.50M	-2.33M	-1.65M	5.44M	-3.59M	-4.96M	-5.66M	-2.45M	-4.35M	-5.52M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.85M	0.95M	0.79M	0.64M	0.58M	0.58M	0.58M	0.56M	0.41M	0.40M	0.14M	0.41M	0.12M	0.12M	0.11M	0.11M	0.06M
Amortization of Deferred Charges (Quarter)	0.03M	0.03M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.37M	0.00M	0.20M		0.12M	0.11M	0.11M	0.06M		0.33M
Depreciation & Amortization (CF) (Quarter)	0.28M	0.28M	0.25M	0.13M	0.12M	0.10M	0.05M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.01M	0.00M	0.01M	0.00M	0.00M	0.01M	0.00M
Change in Working Capital
Change in Receivables (Quarter)		0.04M	0.18M
Change in Inventory (Quarter)	0.13M	-0.79M	-0.78M	-0.33M	-0.17M
Change in Accured Expenses (Quarter)	0.41M	-10.45M	-6.74M	5.84M	8.64M	-1.82M	-0.20M	-1.53M	0.46M	3.32M	1.06M	1.97M	4.42M	-14.30M	1.05M	0.93M	0.99M	0.92M	17.58M	-4.01M
Investing Activities
Capital Expenditures (Quarter)	0.02M	0.01M	0.01M	0.02M
Cash from Investing Activities (Quarter)	-0.02M	-0.01M	-0.01M	-0.02M
Financing Activities
Other financing activities (Quarter)	-16.81M	0.50M	-0.11M	0.65M		0.26M	2.10M	0.70M	0.17M	0.30M							1.06M	0.02M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)	50.00M													0.71M				0.14M
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	17.84M	26.10M	18.80M	10.30M	17.46M	22.00M		22.09M	19.82M	13.24M	14.19M	22.95M	25.85M	25.80M	37.47M	37.37M	38.32M	38.47M	38.47M	31.32M
Net Equity Issued and Repurchased (Quarter)		2.90M	10.70M
Misc.
Cash from Financing Activities (Quarter)	52.48M	4.35M	31.23M	4.55M	7.88M	11.52M	2.33M	14.72M	1.35M	4.02M	0.65M	3.63M	3.44M	9.67M		0.02M	1.17M	-0.12M		16.19M
Change in Cash (Quarter)	19.65M	-27.40M	2.33M	-6.51M	1.87M	0.45M	-2.07M	8.51M	-2.06M	-0.48M	-1.85M	1.30M	1.79M	15.11M	-3.59M	-4.93M	-4.50M	-2.57M	-4.35M	10.67M
Free Cash Flow (Quarter)	-32.83M	-31.75M	-28.90M	-11.06M	-6.04M	-11.07M	-4.41M	-6.22M	-3.41M	-4.50M	-2.50M	-2.33M	-1.65M	5.44M	-3.59M	-4.96M	-5.66M	-2.45M	-4.35M	-5.52M
Net Cash Flow (Quarter)	19.65M	-27.40M	2.33M	-6.51M	1.84M	0.45M	-2.07M	8.51M	-2.06M	-0.48M	-1.85M	1.30M	1.79M	15.11M	-3.59M	-4.93M	-4.50M	-2.57M	-4.35M	10.67M

Research Tools

Developers

CytoDyn Cash Flow Statement (2010-2026) | CYDY

Research Tools

Developers

CytoDyn Cash Flow Statement (2010-2026) | CYDY

Create an account

Sign In

Reset Password